William Cavanagh

This profile gathers the share dealings of William Cavanagh in Perspective Therapeutics, Inc. Over a trading history stretching from 27 May 2014 to 22 October 2020, the count stands at 11 filings.

Both buying and selling appear: 3 purchases worth €10k, against 3 sales worth €118k. On balance, insiders were net sellers of €108k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 5 option exercises. So far in 2020, the count stands at 1 purchase and no sales.

In size, the median ticket on the buying side is €3,532. Of 3 purchases, 3 formed part of a group of insiders buying within 30 days of each other. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. Looking at 3 purchases old enough to measure, the stock rose over the following 90 days in 67% of cases; the median change was +146.2%. These figures describe past trades and do not predict future prices.

The newest entry dates from 28 October 2020: an open-market purchase of €3,385, in Perspective Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 28 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.